Identification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing

Arthritis and Rheumatology

Volumn 68, Issue 1, 2016, Pages 191-200

  Gao, Li ^a   Emond, Mary J ^b   Louie, Tin ^b   Cheadle, Chris ^a   Berger, Alan E ^a   Rafaels, Nicholas ^a   Vergara, Candelaria ^a   Kim, Yoonhee ^c   Taub, Margaret A ^a   Ruczinski, Ingo ^a   Mathai, Stephen C ^a   Rich, Stephen S ^d   Nickerson, Deborah A ^b   Hummers, Laura K ^a   Bamshad, Michael J ^b   Hassoun, Paul M ^a   Mathias, Rasika A ^a   Barnes, Kathleen C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ADENOSINE TRIPHOSPHATASE; ATP8B4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ATP8B4 GENE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CYCLIC NUCLEOTIDE GATED CHANNELOPATHY GENE; E3 UBIQUITIN PROTEIN LIGASE COMPLEX GENE; EUROPEAN AMERICAN; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HEAT SHOCK PROTEIN 27 GENE; HLA DRB5 GENE; HUMAN; HUMAN CELL; KERNEL METHOD; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATOR GENE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; WHOLE EXOME SEQUENCING; CAUCASIAN; COMPLICATION; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; HYPERTENSION, PULMONARY; METABOLISM; MIDDLE AGED; ODDS RATIO; REAL TIME POLYMERASE CHAIN REACTION;

ADENOSINE TRIPHOSPHATASES; ADULT; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; ODDS RATIO; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SEQUENCE ANALYSIS, DNA;

EID: 84952060378     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39449     Document Type: Article

References (46)

1. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al., Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 2246-55.
2. Barnes J, Mayes MD., Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol 2012; 24: 165-70.
3. Steen VD, Medsger TA., Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4.
4. Mathai SC, Hassoun PM., Pulmonary arterial hypertension associated with systemic sclerosis. Expert Rev Respir Med 2011; 5: 267-79.
5. Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, et al., Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 2011; 7: e1002178.
6. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, et al., Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010; 42: 426-9.
7. Allanore Y, Saad M, Dieude P, Avouac J, Distler JH, Amouyel P, et al., Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 2011; 7: e1002091.
8. Bossini-Castillo L, Martin JE, Broen J, Gorlova O, Simeon CP, Beretta L, et al., A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet 2012; 21: 926-33.
9. Martin JE, Broen JC, Carmona FD, Teruel M, Simeon CP, Vonk MC, et al., Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up. Hum Mol Genet 2012; 21: 2825-35.
10. Lopez-Isac E, Bossini-Castillo L, Simeon CP, Egurbide MV, Alegre-Sancho JJ, Callejas JL, et al., A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility. Arthritis Res Ther 2014; 16: R6.
11. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, et al., Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012; 337: 64-9.
12. Manno RL, Wigley FM, Gelber AC, Hummers LK., Late-age onset systemic sclerosis. J Rheumatol 2011; 38: 1317-25.
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
14. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al., Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
15. Velayos EE, Masi AT, Stevens MB, Shulman LE., The 'CREST' syndrome: comparison with systemic sclerosis (scleroderma). Arch Intern Med 1979; 139: 1240-4.
16. LeRoy EC, Medsger TA Jr., Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
17. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al., Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62 Suppl: D34-41.
18. Hansel NN, Ruczinski I, Rafaels N, Sin DD, Daley D, Malinina A, et al., Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. Hum Genet 2013; 132: 79-90.
19. Emond MJ, Louie T, Emerson J, Zhao W, Mathias RA, Knowles MR, et al., Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet 2012; 44: 886-9.
20. Cheadle C, Berger AE, Mathai SC, Grigoryev DN, Watkins TN, Sugawara Y, et al., Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients. PLoS One 2012; 7: e34951.
21. Benjamini Y, Hochberg Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289-300.
22. Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, et al., Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet 2012; 91: 224-37.
23. AHA medical/scientific statement. 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulation 1994; 90: 644-5.
24. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al., A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-9.
25. Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Matucci-Cerinic M, et al., Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 2010; 69: 1958-64.
26. Austin ED, Ma L, LeDuc C, Berman Rosenzweig E, Borczuk A, Phillips JA III, et al., Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension. Circ Cardiovasc Genet 2012; 5: 336-43.
27. Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, et al., A novel channelopathy in pulmonary arterial hypertension. N Engl J Med 2013; 369: 351-61.
28. Hunt KA, Mistry V, Bockett NA, Ahmad T, Ban M, Barker JN, et al., Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 2013; 498: 232-5.
29. Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, et al., Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 2008; 65: 45-53.
30. Kathiresan S, Manning AK, Demissie S, D'Agostino RB, Surti A, Guiducci C, et al., A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. BMC Med Genet 2007; 8 Suppl 1: S17.
31. Sebastian TT, Baldridge RD, Xu P, Graham TR., Phospholipid flippases: building asymmetric membranes and transport vesicles. Biochim Biophys Acta 2012; 1821: 1068-77.
32. Palmgren MG, Nissen P., P-type ATPases. Annu Rev Biophys 2011; 40: 243-66.
33. Kuhlbrandt W., Biology, structure and mechanism of P-type ATPases. Nat Rev Mol Cell Biol 2004; 5: 282-95.
34. +-ATPase. Nat Commun 2012; 3: 669.
35. Van Mil SW, Klomp LW, Bull LN, Houwen RH., FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 2001; 21: 535-44.
36. Wortmann SB, Vaz FM, Gardeitchik T, Vissers LE, Renkema GH, Schuurs-Hoeijmakers JH, et al., Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat Genet 2012; 44: 797-802.
37. Ray NB, Durairaj L, Chen BB, McVerry BJ, Ryan AJ, Donahoe M, et al., Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat Med 2010; 16: 1120-7.
38. Saini-Chohan HK, Dakshinamurti S, Taylor WA, Shen GX, Murphy R, Sparagna GC, et al., Persistent pulmonary hypertension results in reduced tetralinoleoyl-cardiolipin and mitochondrial complex II + III during the development of right ventricular hypertrophy in the neonatal pig heart. Am J Physiol Heart Circ Physiol 2011; 301: H1415-24.
39. Avouac J, Cagnard N, Distler JH, Schoindre Y, Ruiz B, Couraud PO, et al., Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells. Arthritis Rheum 2011; 63: 3552-62.
40. Nishimura Y, Tadokoro S, Tanaka M, Hirashima N., Detection of asymmetric distribution of phospholipids by fluorescence resonance energy transfer. Biochem Biophys Res Commun 2012; 420: 926-30.
41. Fadeel B, Xue D., The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease. Crit Rev Biochem Mol Biol 2009; 44: 264-77.
42. Method of the year 2013. Nat Methods 2014;11:1.
43. Eberwine J, Sul JY, Bartfai T, Kim J., The promise of single-cell sequencing. Nat Methods 2014; 11: 25-7.
44. Keller KE, Yang YF, Sun YY, Sykes R, Acott TS, Wirtz MK., Ankyrin repeat and suppressor of cytokine signaling box containing protein-10 is associated with ubiquitin-mediated degradation pathways in trabecular meshwork cells. Mol Vis 2013; 19: 1639-55.
45. Beavo JA, Brunton LL., Cyclic nucleotide research-still expanding after half a century. Nat Rev Mol Cell Biol 2002; 3: 710-8.
46. Ghofrani HA, Osterloh IH, Grimminger F., Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 2006; 5: 689-702.